English

Lee Pharmaceuticals, Inc.

EDGAR

Filing (10QSB) · filed 2005-08-05

44 filing records in this dataset, filed from 1995-04-12 to 2005-08-05. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

2.23 million USD

2005-06-30 · USD

Exact inputs and evidence

Revenue: 2234000 USD Source

Operating margin

5.24%

2005-06-30 · %

Exact inputs and evidence

Operating Income: 117000 USD Source
Revenue: 2234000 USD Source

Operating cash flow

210 thousand USD

2005-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: 48000 USD Source
Operating Cash Flow: -162000 USD Source

Free cash flow

136 thousand USD

2005-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: 48000 USD Source
Operating Cash Flow: -162000 USD Source
Capital Expenditure: 166000 USD Source
Capital Expenditure: 92000 USD Source

Cash and cash equivalents: 22 thousand USD 2005-06-30 Source
Exact value

22000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2005-08-05.

Financial data available through: 1995-09-30.

Financial coverage is incomplete. Newer filings are recorded, but comparable financial figures for those periods are not available here yet.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 1995-09-30
Operating income: 2 of 11 periods available· newest 1995-09-30
Net income: 2 of 11 periods available· newest 1995-09-30
Operating cash flow: 2 of 11 periods available· newest 1995-09-30
Capital expenditure: 2 of 11 periods available· newest 1995-09-30
Total assets: 1 of 11 periods available· newest 1995-09-30
Total liabilities: 1 of 11 periods available· newest 1995-09-30
Current assets: 1 of 11 periods available· newest 1995-09-30
Current liabilities: 1 of 11 periods available· newest 1995-09-30
Cash and cash equivalents: 2 of 11 periods available· newest 1995-09-30
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-15.9%

Prior period

USD 10.87 million

1993-10-01 – 1994-09-30
Current period

USD 9.14 million

1994-10-01 – 1995-09-30

Exact inputs and evidence

9139000 − 10869000 = -1730000 USD

10869000 USD · 1993-10-01 – 1994-09-30
Inspect prior input Prior source
9139000 USD · 1994-10-01 – 1995-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · Lee Pharmaceuticals, Inc. · 1995-09-30 Lee Pharmaceuticals, Inc. (edgar:58411) Year-over-year change in Revenue: -1730000 USD Concept: fundies:Revenue Period: 1994-10-01 to 1995-09-30 Values: Latest reported Published: 2026-11-02T19:42:16Z Snapshot: f77afb291503b526f7dbd468a81ea43fb01c441b710a55a85f220786db3cc77f Dimensions: Consolidated View: https://fundies.io/companies/edgar/58411?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 9139000 USD (1994-10-01 to 1995-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/58411/0000912057-96-000444.txt#1138 Input fundies:Revenue: 10869000 USD (1993-10-01 to 1994-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/58411/0000912057-96-000444.txt#1138
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 619,000

Prior period

−USD 663,000

1993-10-01 – 1994-09-30
Current period

−USD 1.28 million

1994-10-01 – 1995-09-30

Exact inputs and evidence

-1282000 − -663000 = -619000 USD

-663000 USD · 1993-10-01 – 1994-09-30
Inspect prior input Prior source
-1282000 USD · 1994-10-01 – 1995-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · Lee Pharmaceuticals, Inc. · 1995-09-30 Lee Pharmaceuticals, Inc. (edgar:58411) Year-over-year change in Net income: -619000 USD Concept: fundies:NetIncome Period: 1994-10-01 to 1995-09-30 Values: Latest reported Published: 2026-11-02T19:42:16Z Snapshot: f77afb291503b526f7dbd468a81ea43fb01c441b710a55a85f220786db3cc77f Dimensions: Consolidated View: https://fundies.io/companies/edgar/58411?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -1282000 USD (1994-10-01 to 1995-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/58411/0000912057-96-000444.txt#1211 Input fundies:NetIncome: -663000 USD (1993-10-01 to 1994-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/58411/0000912057-96-000444.txt#1211
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 1.03 million

Prior period

−USD 289,000

1993-10-01 – 1994-09-30
Current period

USD 744,000

1994-10-01 – 1995-09-30

Exact inputs and evidence

744000 − -289000 = 1033000 USD

-289000 USD · 1993-10-01 – 1994-09-30
Inspect prior input Prior source
744000 USD · 1994-10-01 – 1995-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · Lee Pharmaceuticals, Inc. · 1995-09-30 Lee Pharmaceuticals, Inc. (edgar:58411) Year-over-year change in Operating cash flow: 1033000 USD Concept: fundies:OperatingCashFlow Period: 1994-10-01 to 1995-09-30 Values: Latest reported Published: 2026-11-02T19:42:16Z Snapshot: f77afb291503b526f7dbd468a81ea43fb01c441b710a55a85f220786db3cc77f Dimensions: Consolidated View: https://fundies.io/companies/edgar/58411?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 744000 USD (1994-10-01 to 1995-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/58411/0000912057-96-000444.txt#1237 Input fundies:OperatingCashFlow: -289000 USD (1993-10-01 to 1994-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/58411/0000912057-96-000444.txt#1237
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-67.3%

Prior period

USD 300,000

1993-10-01 – 1994-09-30
Current period

USD 98,000

1994-10-01 – 1995-09-30

Exact inputs and evidence

98000 − 300000 = -202000 USD

300000 USD · 1993-10-01 – 1994-09-30
Inspect prior input Prior source
98000 USD · 1994-10-01 – 1995-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · Lee Pharmaceuticals, Inc. · 1995-09-30 Lee Pharmaceuticals, Inc. (edgar:58411) Year-over-year change in Capital expenditure: -202000 USD Concept: fundies:CapitalExpenditure Period: 1994-10-01 to 1995-09-30 Values: Latest reported Published: 2026-11-02T19:42:16Z Snapshot: f77afb291503b526f7dbd468a81ea43fb01c441b710a55a85f220786db3cc77f Dimensions: Consolidated View: https://fundies.io/companies/edgar/58411?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 98000 USD (1994-10-01 to 1995-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/58411/0000912057-96-000444.txt#1241 Input fundies:CapitalExpenditure: 300000 USD (1993-10-01 to 1994-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/58411/0000912057-96-000444.txt#1241
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

1995 1994-10-01 – 1995-09-30

Revenue USD 9.14 million 100% of revenue
Operating costs Derived USD 10.14 million 111% of revenue
Operating income −USD 996,000 −11% of revenue
Tax, interest and other Derived USD 286,000 3.1% of revenue
Net income −USD 1.28 million −14% of revenue

Cash

Operating cash flow USD 744,000 8.1% of revenue
Capital expenditure USD 98,000 1.1% of revenue
Free cash flow Derived USD 646,000 7.1% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1994 Operating loss: operating costs were 105% of revenue.
1995 Operating loss: operating costs were 111% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1994 1993-10-01 – 1994-09-30	10869000	11411000 Derived	-542000	121000 Derived	-663000	-589000 Derived	Source 1993-10-01 – 1994-09-30: 10869000 USD Inspect Revenue Open source 1993-10-01 – 1994-09-30: -542000 USD Inspect Operating Income Open source 1993-10-01 – 1994-09-30: -663000 USD Inspect Net Income Open source 1993-10-01 – 1994-09-30: -289000 USD Inspect Operating Cash Flow Open source 1993-10-01 – 1994-09-30: 300000 USD Inspect Capital Expenditure Open source
1995 1994-10-01 – 1995-09-30	9139000	10135000 Derived	-996000	286000 Derived	-1282000	646000 Derived	Source 1994-10-01 – 1995-09-30: 9139000 USD Inspect Revenue Open source 1994-10-01 – 1995-09-30: -996000 USD Inspect Operating Income Open source 1994-10-01 – 1995-09-30: -1282000 USD Inspect Net Income Open source 1994-10-01 – 1995-09-30: 744000 USD Inspect Operating Cash Flow Open source 1994-10-01 – 1995-09-30: 98000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 9.1M 1995

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-09-30	Revenue	10869000	Revenue: 10869000 Open source
19951995-09-30	Revenue	9139000	Revenue: 9139000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-15.9% 1995

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19941994-09-30	Year over year	No prior comparable period	Revenue: 10869000 Open source
19951995-09-30	Year over year	-15.9%	Revenue: 9139000 Open source Revenue: 10869000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -10.9% 1995

Net margin -14% 1995

Free cash flow margin 7.1% 1995

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19941994-09-30	Operating margin	-5%	Operating Income: -542000 Open source Revenue: 10869000 Open source
19951995-09-30	Operating margin	-10.9%	Operating Income: -996000 Open source Revenue: 9139000 Open source
19941994-09-30	Net margin	-6.1%	Net Income: -663000 Open source Revenue: 10869000 Open source
19951995-09-30	Net margin	-14%	Net Income: -1282000 Open source Revenue: 9139000 Open source
19941994-09-30	Free cash flow margin	-5.4%	Revenue: 10869000 Open source Operating Cash Flow: -289000 Open source Capital Expenditure: 300000 Open source
19951995-09-30	Free cash flow margin	7.1%	Revenue: 9139000 Open source Operating Cash Flow: 744000 Open source Capital Expenditure: 98000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 744K 1995

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-09-30	Operating cash flow	-289000	Operating Cash Flow: -289000 Open source
19951995-09-30	Operating cash flow	744000	Operating Cash Flow: 744000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 646K 1995

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19941994-09-30	Free cash flow	-589000	Operating Cash Flow: -289000 Open source Capital Expenditure: 300000 Open source
19951995-09-30	Free cash flow	646000	Operating Cash Flow: 744000 Open source Capital Expenditure: 98000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

102% 1995

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1994-09-30	Liabilities / assets	Not reported	No source recorded
19951995-09-30	Liabilities / assets	102%	Total Liabilities: 8885000 Open source Total Assets: 8715000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

1.34× 1995

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1994-09-30	Current assets / current liabilities	Not reported	No source recorded
19951995-09-30	Current assets / current liabilities	1.34×	Current Assets: 5001000 Open source Current Liabilities: 3741000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1994 1993-10-01 – 1994-09-30	−USD 663,000 Exact value Exact value: -663000 USD 1993-10-01 – 1994-09-30: -663000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Lee Pharmaceuticals, Inc. · 1994-09-30 Lee Pharmaceuticals, Inc. (edgar:58411) Net Income: -663000 USD Concept: fundies:NetIncome Period: 1993-10-01 to 1994-09-30 Values: Latest reported Published: 2026-11-02T19:42:16Z Snapshot: f77afb291503b526f7dbd468a81ea43fb01c441b710a55a85f220786db3cc77f Dimensions: Consolidated View: https://fundies.io/companies/edgar/58411/explain?concept=fundies%3ANetIncome&period=1994-09-30&surface=latest&period_type=duration&start=1993-10-01&unit=USD&dimensions= Input fundies:NetIncome: -663000 USD (1993-10-01 to 1994-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/58411/0000912057-96-000444.txt#1211 The citation records this snapshot. The page link may show a newer release later.	−USD 289,000 Exact value Exact value: -289000 USD 1993-10-01 – 1994-09-30: -289000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Lee Pharmaceuticals, Inc. · 1994-09-30 Lee Pharmaceuticals, Inc. (edgar:58411) Operating Cash Flow: -289000 USD Concept: fundies:OperatingCashFlow Period: 1993-10-01 to 1994-09-30 Values: Latest reported Published: 2026-11-02T19:42:16Z Snapshot: f77afb291503b526f7dbd468a81ea43fb01c441b710a55a85f220786db3cc77f Dimensions: Consolidated View: https://fundies.io/companies/edgar/58411/explain?concept=fundies%3AOperatingCashFlow&period=1994-09-30&surface=latest&period_type=duration&start=1993-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -289000 USD (1993-10-01 to 1994-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/58411/0000912057-96-000444.txt#1237 The citation records this snapshot. The page link may show a newer release later.	USD 300,000 Exact value Exact value: 300000 USD 1993-10-01 – 1994-09-30: 300000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Lee Pharmaceuticals, Inc. · 1994-09-30 Lee Pharmaceuticals, Inc. (edgar:58411) Capital Expenditure: 300000 USD Concept: fundies:CapitalExpenditure Period: 1993-10-01 to 1994-09-30 Values: Latest reported Published: 2026-11-02T19:42:16Z Snapshot: f77afb291503b526f7dbd468a81ea43fb01c441b710a55a85f220786db3cc77f Dimensions: Consolidated View: https://fundies.io/companies/edgar/58411/explain?concept=fundies%3ACapitalExpenditure&period=1994-09-30&surface=latest&period_type=duration&start=1993-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 300000 USD (1993-10-01 to 1994-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/58411/0000912057-96-000444.txt#1241 The citation records this snapshot. The page link may show a newer release later.	−USD 589,000 Calculation and evidence -289000 − 300000 USD Exact free cash flow: -589000 USD 1993-10-01 – 1994-09-30: -289000 USD · Inspect Operating Cash Flow · Source 1993-10-01 – 1994-09-30: 300000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Lee Pharmaceuticals, Inc. · 1994-09-30 Lee Pharmaceuticals, Inc. (edgar:58411) Free cash flow: -589000 USD Concept: free-cash-flow Period: 1993-10-01 to 1994-09-30 Values: Latest reported Published: 2026-11-02T19:42:16Z Snapshot: f77afb291503b526f7dbd468a81ea43fb01c441b710a55a85f220786db3cc77f Dimensions: Consolidated View: https://fundies.io/companies/edgar/58411?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -289000 USD (1993-10-01 to 1994-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/58411/0000912057-96-000444.txt#1237 Input fundies:CapitalExpenditure: 300000 USD (1993-10-01 to 1994-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/58411/0000912057-96-000444.txt#1241 The citation records this snapshot. The page link may show a newer release later.
1995 1994-10-01 – 1995-09-30	−USD 1.28 million Exact value Exact value: -1282000 USD 1994-10-01 – 1995-09-30: -1282000 USD Inspect Net Income Open source Share or cite Citation for Net Income · Lee Pharmaceuticals, Inc. · 1995-09-30 Lee Pharmaceuticals, Inc. (edgar:58411) Net Income: -1282000 USD Concept: fundies:NetIncome Period: 1994-10-01 to 1995-09-30 Values: Latest reported Published: 2026-11-02T19:42:16Z Snapshot: f77afb291503b526f7dbd468a81ea43fb01c441b710a55a85f220786db3cc77f Dimensions: Consolidated View: https://fundies.io/companies/edgar/58411/explain?concept=fundies%3ANetIncome&period=1995-09-30&surface=latest&period_type=duration&start=1994-10-01&unit=USD&dimensions= Input fundies:NetIncome: -1282000 USD (1994-10-01 to 1995-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/58411/0000912057-96-000444.txt#1211 The citation records this snapshot. The page link may show a newer release later.	USD 744,000 Exact value Exact value: 744000 USD 1994-10-01 – 1995-09-30: 744000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · Lee Pharmaceuticals, Inc. · 1995-09-30 Lee Pharmaceuticals, Inc. (edgar:58411) Operating Cash Flow: 744000 USD Concept: fundies:OperatingCashFlow Period: 1994-10-01 to 1995-09-30 Values: Latest reported Published: 2026-11-02T19:42:16Z Snapshot: f77afb291503b526f7dbd468a81ea43fb01c441b710a55a85f220786db3cc77f Dimensions: Consolidated View: https://fundies.io/companies/edgar/58411/explain?concept=fundies%3AOperatingCashFlow&period=1995-09-30&surface=latest&period_type=duration&start=1994-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 744000 USD (1994-10-01 to 1995-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/58411/0000912057-96-000444.txt#1237 The citation records this snapshot. The page link may show a newer release later.	USD 98,000 Exact value Exact value: 98000 USD 1994-10-01 – 1995-09-30: 98000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · Lee Pharmaceuticals, Inc. · 1995-09-30 Lee Pharmaceuticals, Inc. (edgar:58411) Capital Expenditure: 98000 USD Concept: fundies:CapitalExpenditure Period: 1994-10-01 to 1995-09-30 Values: Latest reported Published: 2026-11-02T19:42:16Z Snapshot: f77afb291503b526f7dbd468a81ea43fb01c441b710a55a85f220786db3cc77f Dimensions: Consolidated View: https://fundies.io/companies/edgar/58411/explain?concept=fundies%3ACapitalExpenditure&period=1995-09-30&surface=latest&period_type=duration&start=1994-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 98000 USD (1994-10-01 to 1995-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/58411/0000912057-96-000444.txt#1241 The citation records this snapshot. The page link may show a newer release later.	USD 646,000 Calculation and evidence 744000 − 98000 USD Exact free cash flow: 646000 USD 1994-10-01 – 1995-09-30: 744000 USD · Inspect Operating Cash Flow · Source 1994-10-01 – 1995-09-30: 98000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · Lee Pharmaceuticals, Inc. · 1995-09-30 Lee Pharmaceuticals, Inc. (edgar:58411) Free cash flow: 646000 USD Concept: free-cash-flow Period: 1994-10-01 to 1995-09-30 Values: Latest reported Published: 2026-11-02T19:42:16Z Snapshot: f77afb291503b526f7dbd468a81ea43fb01c441b710a55a85f220786db3cc77f Dimensions: Consolidated View: https://fundies.io/companies/edgar/58411?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 744000 USD (1994-10-01 to 1995-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/58411/0000912057-96-000444.txt#1237 Input fundies:CapitalExpenditure: 98000 USD (1994-10-01 to 1995-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/58411/0000912057-96-000444.txt#1241 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

44 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000058411, 58411, edgar:58411

Also known as LEE PHARMACEUTICALS

Lee Pharmaceuticals, Inc.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

1995 1994-10-01 – 1995-09-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation